Death during Intensive Glycemic Therapy of Diabetes: Mechanisms and Implications
Open Access
- 30 November 2011
- journal article
- editorial
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 124 (11), 993-996
- https://doi.org/10.1016/j.amjmed.2011.08.008
Abstract
No abstract availableThis publication has 61 references indexed in Scilit:
- Hypoglycemia-associated Mortality Is Not Drug-associated but Linked to ComorbiditiesMaterials, 2011
- Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trialsBMJ, 2011
- Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD TrialDiabetes Care, 2010
- Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic AdultsThe New England Journal of Medicine, 2010
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesThe New England Journal of Medicine, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Long-Term Effect of Diabetes and Its Treatment on Cognitive FunctionThe New England Journal of Medicine, 2007
- Hypoglycemia, functional brain failure, and brain deathJCI Insight, 2007